Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chappell

Showing results (191-200 of 247) with videos related to

Pageof 25
Sort By:
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
The New England Journal of Medicine|December 3, 2020
Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationAlicia T Widge, Nadine G Rouphael, Lisa A Jackson, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depressionBruce A Dressman, Eric G Tromiczak, Mark D Chappell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022Mark W Tenforde, Manish M Patel, Nathaniel M Lewis, et al.
JAMA|January 26, 2023
Household Transmission of Influenza A Viruses in 2021-2022Melissa A Rolfes, H Keipp Talbot, Huong Q McLean, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
The Journal of Infectious Diseases|January 27, 2023
Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022Jessica E Deyoe, J Daniel Kelly, Carlos G Grijalva, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010 - 2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
Epidemiology (Cambridge, Mass.)|May 18, 2022
Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic MisclassificationAvnika B Amin, Timothy L Lash, Jacqueline E Tate, et al.
The Journal of Infectious Diseases|May 6, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010-2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
Pageof 25

Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
The New England Journal of Medicine|December 3, 2020
Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationAlicia T Widge, Nadine G Rouphael, Lisa A Jackson, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depressionBruce A Dressman, Eric G Tromiczak, Mark D Chappell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022Mark W Tenforde, Manish M Patel, Nathaniel M Lewis, et al.
JAMA|January 26, 2023
Household Transmission of Influenza A Viruses in 2021-2022Melissa A Rolfes, H Keipp Talbot, Huong Q McLean, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
The Journal of Infectious Diseases|January 27, 2023
Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022Jessica E Deyoe, J Daniel Kelly, Carlos G Grijalva, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010 - 2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
Epidemiology (Cambridge, Mass.)|May 18, 2022
Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic MisclassificationAvnika B Amin, Timothy L Lash, Jacqueline E Tate, et al.
The Journal of Infectious Diseases|May 6, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010-2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
Pageof 25